Skip to content

Urinary stones a rare side-effect of atazanavir

Return of nelfinavir's European license recommended

ICAAC: High mortality rate from symptomatic lactic acidosis in Thailand

ICAAC: Hardening of the arteries found in one in five patients in Swiss HIV cohort

European researchers develop method of calculating short-term risk of HIV disease progression

T-20 increases tipranavir levels but does not increase risk of liver side-effects

Cognitive impairment common in people with HIV despite antiretroviral therapy

Switch to nevirapine safe for treatment-experienced patients with high CD4 cell counts

Nelfinavir shows promise as a cancer therapy